title: Should Europe have a universal hepatitis B vaccination programme?
authors.affiliation: Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. pierre.vandamme@ua.ac.be
authors.forename: Pierre
authors.initials: P
authors.lastname: Van Damme
authors.forename: Elke
authors.initials: E
authors.lastname: Leuridan
authors.forename: Greet
authors.initials: G
authors.lastname: Hendrickx
authors.forename: Alex
authors.initials: A
authors.lastname: Vorsters
authors.forename: Heidi
authors.initials: H
authors.lastname: Theeten
authors.forename: Tuija
authors.initials: T
authors.lastname: Leino
authors.forename: Mika
authors.initials: M
authors.lastname: Salminen
authors.forename: Markku
authors.initials: M
authors.lastname: Kuusi
mesh_terms: D005060:Europe; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D017589:Immunization Programs / Q000379:methods*
chemical_list: D017325:Hepatitis B Vaccines